Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia Lymphoblastic, Acute”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT03235973
What this trial is testing

Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, Acute
Institut Paoli-Calmettes 29
Testing effectiveness (Phase 2)Study completedNCT00055653
What this trial is testing

Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Roswell Park Cancer Institute
Not applicableUnknownNCT03419494
What this trial is testing

Comparison of Liposomal Doxorubicin and Daunorubicin-containing VDCLD Regimen in the Treatment of Adult ALL Patients

Who this might be right for
Adult Acute Lymphoblastic Leukemia
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07192237
What this trial is testing

Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Phase 2 StudyBlinatumomabAcute Lymphoblastic Leukemia
M.D. Anderson Cancer Center 40
Early research (Phase 1)Ended earlyNCT02588456
What this trial is testing

Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
University of Pennsylvania 5
Large-scale testing (Phase 3)UnknownNCT03391739
What this trial is testing

CART-19 Cells For R/R B-ALL

Who this might be right for
Relapsed/Refractory B-cell ALL
Fujian Medical University 20
Not applicableLooking for participantsNCT06450067
What this trial is testing

Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Juventas Cell Therapy Ltd. 200
Not applicableEnded earlyNCT01685411
What this trial is testing

Busulfan and Cyclophosphamide Followed By ALLO BMT

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 5
Not applicableLooking for participantsNCT06355739
What this trial is testing

CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+

Who this might be right for
B Lymphocytic LeukemiaB Lymphoblastic Lymphoma
Zhu Xiaofan 60
Testing effectiveness (Phase 2)Ended earlyNCT04430530
What this trial is testing

4SCAR-T Therapy Post CD19-targeted Immunotherapy

Who this might be right for
CD19 Negative B-cell Malignancies
Shenzhen Geno-Immune Medical Institute 100
Not applicableStudy completedNCT03803670
What this trial is testing

Clinical Significance of Occult Central Nervous System Disease In Adult Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
University of Rome Tor Vergata 241
Early research (Phase 1)Study completedNCT00357305
What this trial is testing

Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+31 more
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Looking for participantsNCT04544592
What this trial is testing

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaB-cell Non Hodgkin Lymphoma
University of Colorado, Denver 45
Not applicableStudy completedNCT03655587
What this trial is testing

Impact of an Orthotic Intervention in Children With Peripheral Neuropathy

Who this might be right for
Gait, Drop FootChemotherapy-induced Peripheral NeuropathyAcute Lymphocytic Leukemia, Pediatric+2 more
Children's Hospitals and Clinics of Minnesota 27
Not applicableStudy completedNCT00005892
What this trial is testing

Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia

Who this might be right for
Fanconi's AnemiaMyelodysplastic SyndromesLeukemia, Nonlymphocytic, Acute+1 more
Fairview University Medical Center
Not applicableStudy completedNCT01233921
What this trial is testing

Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+86 more
Martin, Paul 6
Testing effectiveness (Phase 2)Looking for participantsNCT06101381
What this trial is testing

CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma

Who this might be right for
Leukemia, Acute LymphoblasticLymphoma, Non-Hodgkin
University of Sao Paulo 81
Testing effectiveness (Phase 2)Ended earlyNCT02419469
What this trial is testing

Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Who this might be right for
LeukemiaPrecursor-B Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma+1 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT03512405
What this trial is testing

Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
CD19 PositivePhiladelphia Chromosome PositiveRecurrent Acute Lymphoblastic Leukemia+1 more
City of Hope Medical Center 36
Large-scale testing (Phase 3)Looking for participantsNCT05327894
What this trial is testing

Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaMixed Phenotype Acute Leukemia
Princess Maxima Center for Pediatric Oncology 160
Next Page